Interpretative comments on autoantibody tests

Autoimmunity Reviews

Volumn 6, Issue 6, 2007, Pages 341-346

  Tonutti, Elio ^a   Visentini, Daniela ^a   Bizzaro, Nicola ^b  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b Ospedale Civile di Tolmezzo   (Italy)

Author keywords

Autoantibodies; Interpretative comment; Unexpected autoantibody result

Indexed keywords

AUTOANTIBODY;

AGE DISTRIBUTION; ANTIBODY DETECTION; AUTOIMMUNE DISEASE; CLINICAL IMMUNOLOGY; CORRELATION ANALYSIS; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; HUMAN; IMMUNOASSAY; IMMUNOLOGICAL PROCEDURES; PATIENT CODING; PREDICTION AND FORECASTING; REVIEW; SEX DIFFERENCE;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; DIAGNOSTIC ERRORS; HUMANS; IMMUNOLOGIC TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS;

EID: 34249291305     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.01.007     Document Type: Review

References (34)

1. Plebani M. What information on quality specifications should be communicated to clinicians, and how?. Clin Chim Acta 346 (2004) 25-35
2. ISO 15189: 2003. Medical laboratories. Particular requirements for quality and competence.
3. Lim E.M., Sikaris K.A., Gill J., Calleja J., Hickman P.E., Beilby J., et al. Quality assessment of interpretative commenting in clinical chemistry. Clin Chem 50 (2004) 632-637
4. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C.P., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 42 (1999) 1309-1311
5. Hochberg M.C. The American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthitis Rheum 40 (1997) 1725
6. Vitali C., Bombardieri S., Moutsopulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al. Assessment of the European classification criteria for Sjogren syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 55 (1993) 116-121
7. Oertelt S., Selmi C., Invernizzi P., Podda M., and Gershwin M.E. Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmun Rev 4 (2005) 414-422
8. Utz P.J. Protein arrays for studying blood cells and their secreted products. Immunol Rev 204 (2005) 264-282
9. Bizzaro N., and Wiik A. Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 22 (2004) 349-355
10. Tozzoli R., Bizzaro N., Tonutti E., Villalta D., Bassetti D., Manoni F., et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117 (2002) 316-324
11. Takasaky Y., Kogure T., Takeuchi K., Kaneda K., Yano T., Hirokawa K., et al. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiple protein complexes involved in cell proliferation. J Immunol 166 (2001) 4780-4787
12. Kogure T., Takasaky Y., Takeuchi K., Yamada H., Nawata M., Ikeda K., et al. Autoimmune responses to PCNA multiprotein complexes involved in cell proliferation are strongly associated with their structure and biological function in patients with systemic lupus erythematosus. Arthritis Rheum 46 (2002) 2946-2956
13. Ganapathy V., and Casiano C.A. Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us?. Arthritis Rheum 50 (2004) 684-688
14. Savige J., Dimech W., Fritzler M., Goeken J., Hagen E.C., Jennette J.C., et al. Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Am J Clin Pathol 120 (2003) 312-318
15. Radice A., and Sinico R.A. Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 38 (2005) 93-103
16. Wellmann U., Letz K., Herrmann M., Angermuller S., Kalden J.R., and Winkler T.H. The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci U S A 102 (2005) 9258-9263
17. Savige J., Gillis D., Benson E., Davies D., Esnault V., Falk R.J., et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111 (1999) 507-513
18. Terjung B., Spengler U., Sauerbruch T., and Worman H.J. Atypical p-ANCA in IBD and hepatobilary disorders react with a 50 kD nuclear envelop protein of neutrophils and myeloid cell lines. Gastroenterology 199 (2000) 310-322
19. Mulder A.H., Horst G., Haagsma E.B., Kleibeuker J.H., and Kallenberg C.G. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 17 (1993) 411-417
20. Coremans I.E., Hagen E.C., van der Voort E.A., van der Woude F.J., Daha M.R., and Breedveld F.C. Autoantibodies to neutrophil cytoplasmic enzymes in Felty's syndrome. Clin Exp Rheumatol 11 (1993) 255-262
21. Micheloud D., Sanchez-Ramon D., Carbone J., Rodriguez-Molina J.J., Fernandez-Cruz E., Lopez-Longo F.J., et al. Discordance between anti-beta2-glycoprotein-I and anti-cardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome. Clin Exp Rheumatol 23 (2005) 525-528
22. Wiik A. Granulocyte-specific antinuclear antibodies: possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy 35 (1980) 263-289
23. Laposata M. Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them?. Clin Chem 50 (2004) 471-472
24. Brusco G., Muzi P., Ciccocioppo R., Biagi F., Cifone M.G., and Corazza G.R. Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression. Clin Exp Immunol 118 (1999) 371-375
25. Tonutti E., Visentini D., Bizzaro N., Caradonna M., Cerni L., Villalta D., et al. The role of antitissue transglutaminase assay for the diagnosis and monitoring of celiac disease: a French-Italian multicentre study. J Clin Pathol 56 (2003) 389-393
26. Hoffenberg E.J., MacKenzie T., Barriga K.J., Eisembarth G.S., Bao F., Haas J.E., et al. A prospective study of the incidence of childhood celiac disease. J Pediatr 143 (2003) 308-314
27. Sinclair D., and Duncan H. What happens to patients with positive tissue transglutaminase and endomysium antibody results in general practice?. J Clin Pathol 57 (2004) 943-945
28. Neuberger J., and Bradwell A.R. Anti-mitochondrial antibodies in primary biliary cirrhosis. J Hepatol 37 (2002) 712-716
29. Koulentaki M., Moscandrea J., Dimoulios P., Chatzicostas C., and Kouroumalis E.A. Survival of anti-mitochondrial antibody-positive and-negative primary biliary cirrhosis patients on urodeoxycholic acid treatment. Dig Dis Sci 49 (2004) 1190-1195
30. Lock R.J., Gilmour J.E., and Unsworth D.J. Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies; the antibody trinity of coeliac disease. Clin Exp Immunol 116 (1999) 258-262
31. Ascher H., Hahn-Zoric M., Hanson L.A., Kilander A.F., Nilsson L.A., and Tlaskalova H. Value of serologic markers for clinical diagnosis and population studies of coeliac disease. Scand J Gastroenterol 3 (1996) 61-67
32. Sandborn W.J. Serologic markers in inflammatory bowel disease: state of the art. Rev Gastroenterol Disord 4 (2004) 167-174
33. Damoiseaux J.G., Bouten B., Linders A.M., Austen J., Roozendaal C., Russel M.G., et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol 22 (2002) 281-288
34. Berta Z., Czipo I., Szabo G.G., and Szegedi G. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J Gastroenterol 9 (2003) 2308-2312